(Q38734416)

5 September 2017

Association Between Periodontitis and Amyloid-β Peptide in Elderly People With and Without Cognitive Impairment (English)

1 reference

5 September 2017

0 references

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

José Antonio Gil-Montoya

1

1 reference

5 September 2017

Rocío Barrios

2

1 reference

5 September 2017

Soraya Santana

3

1 reference

5 September 2017

Inés Sanchez-Lara

4

1 reference

5 September 2017

Cristobal Carnero Pardo

5

1 reference

5 September 2017

Francisco Fornieles-Rubio

6

1 reference

5 September 2017

Juan Montes

7

1 reference

5 September 2017

Carlos Ramírez

8

1 reference

5 September 2017

Miguel Angel González-Moles

9

1 reference

5 September 2017

Javier S Burgos

10

1 reference

5 September 2017

language of work or name

English

0 references

publication date

9 June 2017

1 reference

Journal of Periodontology

5 September 2017

1 reference

5 September 2017

1-10

1 reference

Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system

5 September 2017

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Contribution of systemic inflammation to chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Role of neuroinflammation in neurodegeneration: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

The amyloid hypothesis of Alzheimer's disease at 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Periodontal systemic associations: review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Oral health and cognitive function in the Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Periodontitis is associated with cognitive impairment among older adults: analysis of NHANES-III

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Can oral infection be a risk factor for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Periodontal disease associates with higher brain amyloid load in normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Amyloid beta (A4) precursor protein expression in human periodontitis-affected gingival tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Poor oral health as a chronic, potentially modifiable dementia risk factor: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Is periodontitis a risk factor for cognitive impairment and dementia? A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Effectiveness and costs of phototest in dementia and cognitive impairment screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Serum creatinine levels correlate with plasma amyloid Beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Association Between Oral Health and Cognitive Status: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Inflammation and Alzheimer's disease: possible role of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Plasma β-amyloid in Alzheimer's disease and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Imatinib methanesulfonate reduces hippocampal amyloid-β and restores cognitive function following repeated endotoxin exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2017.170071

21 January 2018

Identifiers

DOI

10.1902/JOP.2017.170071

1 reference

5 September 2017

1 reference